Table 3.
Oxidative stress markers before (*) and after (**) first administration of cisplatin-based chemotherapy in non-small cell lung cancer patients.
| Initials of the patient | GSH* | GSH** | SH* | SH** | dROM* | dROM** | NO* | NO** |
|---|---|---|---|---|---|---|---|---|
| S.E | 3.134 | 3.058 | 5.517 | 5.339 | 4.27 | 4.39 | 39.205 | 27.653 |
| J.Z | 2.619 | 3.188 | 6.249 | 6.432 | 3.609 | 3.397 | 54.728 | 95.626 |
| G.H | 2.397 | 2.298 | 5.917 | 6.461 | 3.561 | 3.628 | 84.708 | 83.838 |
| LS | 3.103 | 3.103 | 5.032 | 6.78 | 4.209 | 4.234 | 21.166 | 10.685 |
| D.I | 3.663 | 3.587 | 7.158 | 6.502 | 2.397 | 2.652 | 8.451 | 32.471 |
| Z.J | 3.789 | 3.322 | 6.577 | 6.714 | 3.628 | 4.331 | 41.319 | 36.147 |
| S.J | 2.56 | 2.167 | 4.916 | 6.24 | 3.925 | 3.937 | 16.348 | 22.33 |
| R.W | 2.362 | 2.425 | 4.507 | 2.497 | 3.428 | 3.179 | 52.077 | 93.873 |
| O.T | 1.86 | 2.083 | 8.304 | 2.335 | 4.852 | 2.391 | 28.441 | 129.954 |
| S.A | 2.586 | 2.974 | 2.701 | 4.204 | 3.561 | 3.149 | 18.11 | 17.256 |
| P.L | 3.864 | 4.004 | 2.452 | 2.78 | 2.458 | 2.864 | 34.6 | 37.576 |
| B.M | 2.753 | 3.09 | 2.307 | 2.656 | 4.282 | 3.888 | 27.8 | 33.67 |